We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+13.99%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.33B
AUM Growth
+$796M
Cap. Flow
-$12M
Cap. Flow %
-0.16%
Top 10 Hldgs %
60.07%
Holding
377
New
123
Increased
61
Reduced
77
Closed
82

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$68.6M
2
ARGX icon
argenx
ARGX
+$55M
3
SNY icon
Sanofi
SNY
+$50.7M
4
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$50.5M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$42.3M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$48.6M
2
KDP icon
Keurig Dr Pepper
KDP
+$45.5M
3
INCY icon
Incyte
INCY
+$45.2M
4
UNH icon
UnitedHealth
UNH
+$37.3M
5
CPB icon
Campbell Soup
CPB
+$32M

Sector Composition

Rank Sector Weight
1 Healthcare 34.97%
2 Consumer Staples 5.35%
3 Consumer Discretionary 4.92%
4 Technology 3.86%
5 Communication Services 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AREB
251
DELISTED
American Rebel
AREB
– –
0
– –
DRMA icon
252
Dermata Therapeutics
DRMA
$4.46M
$133K ﹤0.01%
+1,453
New +$157K
SQFTW icon
253
Presidio Property Trust Inc Series A Warrants
SQFTW
$198K
$120K ﹤0.01%
+2,000,000
New +$70K
FGIWW
254
FGI Industries Warrant
FGIWW
$225K
$112K ﹤0.01%
933,333
– –
PTON icon
255
Peloton Interactive
PTON
$2.43B
$105K ﹤0.01%
+17,188
New +$92.6K
STAF
256
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
$101K ﹤0.01%
25,083
-10,800
-30% -$57.8K
VTAK icon
257
Catheter Precision
VTAK
$987K
$98.4K ﹤0.01%
1,280
-337
-21% -$27.5K
MOBBW
258
Mobilicom Ltd Warrants
MOBBW
$2.83B
$88.9K ﹤0.01%
242,100
– –
INM icon
259
InMed Pharmaceuticals
INM
$7.69M
$85.7K ﹤0.01%
+10,298
New +$100K
EZRA
260
Reliance Global Group
EZRA
$2.13M
$84.7K ﹤0.01%
+232
New +$205K
OPEN icon
261
Opendoor
OPEN
$3.44B
$77.5K ﹤0.01%
+17,884
New +$49.9K
DCOY
262
Decoy Therapeutics
DCOY
$2.09M
$57.2K ﹤0.01%
61
-95
-61% -$94.8K
SBEV.WS
263
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$45.1K ﹤0.01%
904,000
– –
LCFYW icon
264
Locafy Ltd Warrant
LCFYW
$37.8K ﹤0.01%
242,425
+230,304
+1,900% +$946K
ONFOW icon
265
Onfolio Holdings Warrant
ONFOW
$47.6K
$32K ﹤0.01%
400,000
– –
BJDX icon
266
Bluejay Diagnostics
BJDX
$1.14M
$29.6K ﹤0.01%
+15
New +$81.3K
SVREW
267
SaverOne 2014 Ltd Warrant
SVREW
$29.1K ﹤0.01%
242,100
– –
NLSPW
268
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$28.1K ﹤0.01%
500,000
– –
PETVW
269
DELISTED
PetVivo Holdings, Inc. Warrant
PETVW
$28K ﹤0.01%
200,000
– –
MTEKW icon
270
Maris-Tech Ltd Warrants
MTEKW
$25.5K ﹤0.01%
1,261,058
– –
ACONW icon
271
Aclarion Warrant
ACONW
$60K
$22K ﹤0.01%
550,000
– –
SWAGW icon
272
Stran & Company Warrant
SWAGW
$66.4K
$21.8K ﹤0.01%
545,000
– –
KTTAW icon
273
Pasithea Therapeutics Warrants
KTTAW
$18K ﹤0.01%
1,000,000
– –
STKH
274
Steakholder Foods
STKH
$1.2M
$18K ﹤0.01%
26
-72
-73% -$55.9K
HSCSW icon
275
HeartSciences Inc Warrant
HSCSW
$71K
$17.6K ﹤0.01%
352,941
– –
9 10
11
12 13

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Armistice Capital held 377 positions worth $7.33B, up 12% from $6.53B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Armistice Capital's Q4 2023 filing shows 123 new, 61 increased, 77 reduced and 82 closed positions. Its largest new stake was Sanofi: 1,036,000 shares worth $51.5M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $48.6M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q4 2023 buy was Sanofi: 1,036,000 shares worth $51.5M.
  • Armistice Capital added most to GSK in Q4 2023, an estimated $68.6M increase.
  • Armistice Capital's biggest Q4 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $48.6M.
  • Armistice Capital fully exited Keurig Dr Pepper in Q4 2023, selling an estimated $45.5M.
  • Armistice Capital's ten largest holdings make up 60% of its $7.33B portfolio in Q4 2023.
  • Armistice Capital opened 123 new positions and closed 82 in Q4 2023.
  • Armistice Capital's portfolio value rose 12% quarter-over-quarter to $7.33B.

Based on Armistice Capital's 13F filing for Q4 2023, filed 13 Feb 2024.